Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Surg Oncol ; 20(5): 1470-81, 2013 May.
Article in English | MEDLINE | ID: mdl-23212762

ABSTRACT

BACKGROUND: The variable incidence of gallbladder cancer (GBCA) suggests regional pathogenetic differences. This study compares cell cycle-regulatory, angiogenesis-related, and PI3K pathway protein expression in GBCAs from three continents. METHODS: Immunohistochemical expression of several proteins was assessed, correlated with clinicopathologic variables, and compared among centers from Chile (Fundación Arturo López Pérez [FALP]), Japan (Yokohama City University [YCU]), and the United States (Memorial Sloan-Kettering Cancer Center [MSKCC]). Hierarchical clustering was used to partition the data based on protein-expression and treatment center. RESULTS: Tissue from 117 patients (MSKCC = 76; FALP = 22; YCU = 19) was analyzed. Mdm2 overexpression was seen only at MSKCC (p < 0.0001). Absence of p21 (p = 0.03) and VEGFR2 (p = 0.018) were more common and p27 expression was less frequent (p = 0.047) in tumors from YCU. Ki-67 labeling index in YCU tumors (median = 10) was two-thirds lower than at other centers. On hierarchical clustering analysis, all YCU patients (p = 0.017) and those with early tumors (p = 0.017) clustered separately from MSKCC. Median disease-specific survival after curative intent (R0) resection was 27 months and was similar among centers (p = 0.9). Median disease-specific survival of patients with early tumors was 28.4 months and was higher at YCU (not reached, p = 0.06). CONCLUSIONS: Cell cycle-regulatory protein expression patterns of YCU tumors differed from those treated at FALP and MSKCC. The differential clustering of protein expression and survival in patients with early tumors suggest regional differences in pathogenesis and disease biology.


Subject(s)
Gallbladder Neoplasms/metabolism , Gallbladder Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Chile , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Female , Gallbladder Neoplasms/surgery , Humans , Japan , Kaplan-Meier Estimate , Ki-67 Antigen/metabolism , Male , Middle Aged , Multivariate Analysis , Neoplasm Staging , Proliferating Cell Nuclear Antigen/metabolism , Proto-Oncogene Proteins c-mdm2/metabolism , United States , Vascular Endothelial Growth Factor Receptor-2/metabolism
2.
Am J Surg Pathol ; 36(3): 402-8, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22082608

ABSTRACT

Although pancreatic acinar metaplasia in the gastric mucosa is well recognized in chronic gastritis, gastric carcinoma with acinar differentiation is very rare. We encountered a case of gastric adenocarcinoma with prominent histologic and immunohistochemical features of pancreatic acinar differentiation in the absence of identifiable heterotopic pancreatic tissue. Distinct glandular and diffuse patterns of adenocarcinoma were also present, and there was focal mucin production. The tumor strongly expressed pancreatic exocrine enzymes trypsin and chymotrypsin, and focal neuroendocrine staining was also present. To investigate the prevalence of acinar differentiation in histologically typical gastric cancers, we performed immunohistochemical staining for trypsin and chymotrypsin on a tissue microarray containing 111 conventional gastric adenocarcinomas (60 intestinal, 28 mixed, 22 diffuse type, and 1 undifferentiated). No obvious morphologic evidence of acinar differentiation was identified in any of the 111 cases. Although some cases showed equivocal staining for at least 1 pancreatic exocrine enzyme on the initial tissue microarray sections, repeat immunohistochemical staining on representative whole-tissue sections failed to reproduce positive staining. Thus, acinar differentiation is rare in gastric adenocarcinomas, other than in histologically unusual cases such as the one we report, and in others from the literature, which are reviewed.


Subject(s)
Biomarkers, Tumor/analysis , Carcinoma, Acinar Cell/enzymology , Carcinoma, Acinar Cell/pathology , Cell Differentiation , Chymotrypsin/analysis , Immunohistochemistry , Stomach Neoplasms/enzymology , Stomach Neoplasms/pathology , Trypsin/analysis , Adult , Aged , Aged, 80 and over , Biopsy , Carcinoma, Acinar Cell/surgery , Female , Gastrectomy , Humans , Male , Metaplasia , Middle Aged , Stomach Neoplasms/surgery , Tissue Array Analysis
3.
Ann Diagn Pathol ; 13(1): 41-6, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19118781

ABSTRACT

Chondromyxoid fibroma (CMF) is a rare benign cartilaginous tumor that usually arises from the metaphysis of long bones. In rare cases, however, CMF presents in unusual locations, such as the facial bones and sinonasal tract. We present a case of a 60-year-old woman with a CMF of the nasal septum. The initial radiographic findings were suggestive of a vascular tumor or a malignancy, but microscopic examination revealed the typical pathologic features of CMF, and SOX9 immunostaining confirmed its cartilaginous origin. The tumor was successfully excised, and the patient was free of disease at 12-month follow-up. Recognizing CMF is important when it presents in unexpected locations, especially because of its histologic resemblance to chondrosarcoma. We believe that the use of SOX9 in our case assisted in the recognition of the chondroid nature of the lesion and facilitated the diagnosis of CMF.


Subject(s)
Chondroma/pathology , Fibroma/pathology , Nasal Septum/pathology , Paranasal Sinus Neoplasms/pathology , Chondroma/diagnostic imaging , Chondroma/surgery , Diagnosis, Differential , Female , Fibroma/diagnostic imaging , Fibroma/surgery , Humans , Immunohistochemistry , Middle Aged , Nasal Septum/diagnostic imaging , Nasal Septum/surgery , Paranasal Sinus Neoplasms/diagnostic imaging , Paranasal Sinus Neoplasms/surgery , SOX9 Transcription Factor/analysis , Tomography, X-Ray Computed , Treatment Outcome
4.
Ann Diagn Pathol ; 11(6): 407-12, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18022124

ABSTRACT

Mucoepidermoid carcinoma (MEC) comprises approximately 30% of all salivary gland malignancies, making it the most common malignant tumor of the salivary glands. Multiple histologic variants with a wide range of differentiation have been described. Sclerosing MEC (SMEC) is a rare subtype that may be misdiagnosed as a benign reactive condition or low-grade non-SMEC malignancy. We report 4 cases of SMEC and evaluated them with Her-2/neu and MIB-1 to determine whether an association exists between the histologic grade and immunohistochemical findings. In 3 cases, histologic examination demonstrated relatively well-circumscribed, nonencapsulated tumors composed of extensive central sclerosis with keloid-like stroma and scattered epithelial islands of low-grade MEC. In the fourth case, the tumor showed similar sclerotic stroma; but the epithelial component was of intermediate grade. In all 4 cases, eosinophils and neutrophils were part of the inflammatory infiltrate; and the edges were surrounded by lymphoid tissue, with germinal center formation and residual epithelial islands. A Mayer mucicarmine stain revealed abundant intracytoplasmic mucin. We found MIB-1 labeling indices of 5% or less in cases 1, 2, and 3 and 12% in case 4, suggesting an association between MIB-1 index and tumor grade. The tumors were negative for Her-2/neu in all 4 cases. The latter seems to bear no relationship to tumor grade.


Subject(s)
Carcinoma, Mucoepidermoid/metabolism , Carcinoma, Mucoepidermoid/pathology , Salivary Gland Neoplasms/metabolism , Salivary Gland Neoplasms/pathology , Adolescent , Adult , Aged , Female , Humans , Immunohistochemistry , Ki-67 Antigen/metabolism , Male , Middle Aged , Receptor, ErbB-2/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...